Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NYSE:AVNSNASDAQ:AXGNNASDAQ:EYENASDAQ:SKIN On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAVNSAvanos Medical$12.28-0.4%$13.69$11.84▼$25.36$564.92M1.15338,855 shs362,319 shsAXGNAxoGen$17.13+3.9%$17.21$5.55▼$21.00$759.61M1.19431,968 shs535,272 shsEYENational Vision$13.14+1.9%$12.16$9.56▼$18.68$1.04B1.021.67 million shs2.05 million shsSKINBeauty Health$1.14+10.7%$1.18$0.78▼$3.63$142.78M0.841.07 million shs218,752 shs(Almost) Everything You Need To Know About The EV MarketLooking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAVNSAvanos Medical-0.45%-0.57%-15.31%-28.81%-34.66%AXGNAxoGen+3.94%+4.45%-3.17%-5.93%+161.13%EYENational Vision+1.86%+6.83%+2.02%+15.26%-25.76%SKINBeauty Health+10.68%+15.12%-22.97%-31.74%-64.04%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAVNSAvanos Medical2.2008 of 5 stars0.03.00.00.01.82.52.5AXGNAxoGen2.9593 of 5 stars3.53.00.00.03.02.50.6EYENational Vision1.3373 of 5 stars1.11.00.03.32.90.00.0SKINBeauty Health2.0405 of 5 stars3.02.00.00.02.63.30.0Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAVNSAvanos Medical 2.00HoldN/AN/AAXGNAxoGen 3.00Buy$22.6031.93% UpsideEYENational Vision 2.17Hold$14.006.54% UpsideSKINBeauty Health 2.00Hold$2.50119.30% UpsideCurrent Analyst Ratings BreakdownLatest SKIN, EYE, AXGN, and AVNS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/17/2025AXGNAxoGenLake Street CapitalSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$30.003/13/2025SKINBeauty HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetHold ➝ Hold$1.75 ➝ $1.503/7/2025EYENational VisionCitigroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetNeutral ➝ Neutral$12.00 ➝ $13.003/5/2025AXGNAxoGenCantor FitzgeraldSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$24.00 ➝ $24.003/3/2025EYENational VisionBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$12.00 ➝ $14.002/27/2025EYENational VisionWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetEqual Weight ➝ Equal Weight$12.00 ➝ $13.002/26/2025AXGNAxoGenCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$22.00 ➝ $26.002/3/2025AXGNAxoGenCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$18.00 ➝ $22.00(Data available from 5/3/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAVNSAvanos Medical$687.80M0.82$1.61 per share7.64$26.63 per share0.46AXGNAxoGen$187.34M4.05N/AN/A$2.22 per share7.72EYENational Vision$1.82B0.57$1.87 per share7.03$10.60 per share1.24SKINBeauty Health$334.29M0.43N/AN/A$0.48 per share2.38Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAVNSAvanos Medical-$61.80M-$8.5336.127.10N/A2.30%4.70%3.46%5/6/2025 (Estimated)AXGNAxoGen-$21.72M-$0.22N/AN/AN/A-7.91%-14.91%-7.49%5/8/2025 (Estimated)EYENational Vision-$65.90M-$0.36N/A48.673.27-0.81%3.52%1.39%5/7/2025 (Estimated)SKINBeauty Health-$100.12M-$0.43N/AN/AN/A-8.11%-44.83%-3.54%5/8/2025 (Estimated)Latest SKIN, EYE, AXGN, and AVNS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/8/2025Q1 2025AXGNAxoGen-$0.01N/AN/AN/A$48.35 millionN/A5/8/2025Q1 2025SKINBeauty Health-$0.13N/AN/AN/A$63.88 millionN/A5/7/2025Q1 2025EYENational Vision$0.32N/AN/AN/A$510.30 millionN/A5/6/2025Q1 2025AVNSAvanos Medical$0.19N/AN/AN/A$161.75 millionN/A3/12/2025Q4 2024SKINBeauty Health-$0.10-$0.08+$0.02-$0.08$78.02 million$83.50 million2/26/2025Q4 2024AVNSAvanos Medical$0.40$0.43+$0.03-$8.64$177.23 million$179.60 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAVNSAvanos MedicalN/AN/AN/AN/AN/AAXGNAxoGenN/AN/AN/AN/AN/AEYENational VisionN/AN/AN/AN/AN/ASKINBeauty HealthN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAVNSAvanos Medical0.122.221.46AXGNAxoGen0.673.742.47EYENational Vision0.300.570.37SKINBeauty Health9.236.565.57Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAVNSAvanos Medical95.17%AXGNAxoGen80.29%EYENational VisionN/ASKINBeauty Health93.26%Insider OwnershipCompanyInsider OwnershipAVNSAvanos Medical2.64%AXGNAxoGen7.00%EYENational Vision2.30%SKINBeauty Health41.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAVNSAvanos Medical4,04046.00 million44.15 millionOptionableAXGNAxoGen45044.34 million40.93 millionOptionableEYENational Vision14,00079.05 million76.94 millionOptionableSKINBeauty Health1,030125.25 million73.23 millionOptionableSKIN, EYE, AXGN, and AVNS HeadlinesRecent News About These CompaniesFrom Sturgeon DNA to Malassezin, Starry Beauty Pros Are Using These Buzzy Science-Backed Ingredients to Prep Clients for the Met Gala and CannesMay 3 at 6:47 AM | yahoo.comBeauty Health (SKIN) Projected to Post Quarterly Earnings on ThursdayMay 3 at 3:50 AM | marketbeat.comHer ‘Caveman’ Skin Care Routine Has Skeptics, but She Says It’s RealMay 2 at 8:39 PM | nytimes.comExperts Share The Best Sensitive Skin Moisturizers For Calm, Glowing SkinMay 2 at 3:38 PM | msn.comDr Annie Black On Skin Health, Beta-Glucan And Reformulating An IconMay 2 at 10:37 AM | msn.comMarigold flower: Natural healing balm for your skinMay 2 at 10:37 AM | newsbytesapp.comIngestible Beauty: What Is It And Why It’s TrendingMay 2 at 5:36 AM | herzindagi.comAging SkinMay 1 at 6:13 AM | soycarmin.comBeauty Health (SKIN) Expected to Announce Earnings on ThursdayMay 1 at 3:51 AM | americanbankingnews.comAmazon Beauty Sale: Save up to 35% on these men’s skincare dealsMay 1 at 1:12 AM | yahoo.comGlow from Within: The Ultimate Beauty Breakfast GuideMay 1 at 1:12 AM | harpersbazaararabia.comOur 8 favourite beauty tech tools for smooth, glowing skinMay 1 at 1:12 AM | msn.comRare Beauty’s Top 5 Products for a Natural, Minimalist LookMay 1 at 1:12 AM | latimes.comCan a skincare serum really help you live longer? The truth about beauty's new longevity obsessionApril 30 at 8:10 PM | womenshealthmag.comSaggy Skin Causes and How to Tighten ItApril 30 at 8:10 PM | msn.comWhy lemon water might be your skin’s best friendApril 30 at 8:10 PM | rollingout.comThe Trendy Caveman Skin Care Method Might Need to be Left in the PastApril 30 at 8:10 PM | msn.com16 Barrier Creams That Dermatologists Swear By for Every Skin TypeApril 30 at 8:10 PM | msn.com13 Dermatologist-Approved Tips to Improve Skin TextureApril 30 at 8:10 PM | msn.comAmazon Summer Beauty Sale 2025: Shop Up to 40% Off SPF, Skincare, Makeup, and MoreApril 29, 2025 | womenshealthmag.comThe 15 Best Expert-Approved Eye Creams for Sensitive SkinApril 29, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesTesla Stock Eyes Breakout With Earnings on DeckBy Sam Quirke | April 16, 2025View Tesla Stock Eyes Breakout With Earnings on DeckJoby Aviation Shares Eye Breakout After Transition Flight WinBy Jeffrey Neal Johnson | April 30, 2025View Joby Aviation Shares Eye Breakout After Transition Flight WinSpotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?By Gabriel Osorio-Mazilli | April 5, 2025View Spotify Stock Eyes Double-Digit Upside—Is Now the Time to Buy?Reddit Stock Eyes Double-Digit Upside on Analyst TargetsBy Gabriel Osorio-Mazilli | April 11, 2025View Reddit Stock Eyes Double-Digit Upside on Analyst TargetsMeta Eyes India: Breaking Down Its Quest for Reliance PartnershipBy Leo Miller | April 7, 2025View Meta Eyes India: Breaking Down Its Quest for Reliance PartnershipSKIN, EYE, AXGN, and AVNS Company DescriptionsAvanos Medical NYSE:AVNS$12.28 -0.05 (-0.41%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$12.28 +0.01 (+0.04%) As of 05/2/2025 04:09 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Avanos Medical, Inc., a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions. The company also provides a portfolio of non-opioid pain solutions, including surgical pain and recovery products, such as ON-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems. In addition, it offers interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy; OrthogenRx's knee osteoarthritis hyaluronic acid pain relief injection products; and Trident radiofrequency ablation products to treat chronic pain conditions. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.AxoGen NASDAQ:AXGN$17.13 +0.65 (+3.94%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$17.56 +0.43 (+2.52%) As of 05/2/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.AxoGen, Inc., together with its subsidiaries, develops and commercializes technologies for peripheral nerve regeneration and repair worldwide. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; AxoGuard Nerve Connector, a porcine submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves; AxoGuard Nerve Protector, a porcine submucosa ECM product that is used to wrap and protect damaged peripheral nerves, as well as reinforces the nerve reconstruction while preventing soft tissue attachments; and Axoguard HA+ Nerve Protector, a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating designed to provide short- and long-term protection for peripheral nerve injuries. Its products also comprise Axoguard Nerve Cap, a porcine submucosa ECM product that is used to protect a peripheral nerve end, as well as separates the nerve from the surrounding environment to reduce the development of symptomatic or painful neuroma; and AxoTouch two-point discriminator, a tool that is used for measuring the innervation density of surface area of the skin. The company provides its products to hospitals, surgery centers, and military hospitals, plastic reconstructive surgeons, orthopedic and plastic hand surgeons, and various oral and maxillofacial surgeons. AxoGen, Inc. is headquartered in Alachua, Florida.National Vision NASDAQ:EYE$13.14 +0.24 (+1.86%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$13.47 +0.33 (+2.51%) As of 05/2/2025 06:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.National Vision Holdings, Inc., through its subsidiaries, operates as an optical retailer in the United States. The company operates in two segments, Owned & Host and Legacy. It offers eyeglasses and contact lenses, and optical accessory products; provides eye exams through its America's Best, Eyeglass World, Vista Optical, Fred Meyer, and Vista Optical military, as well as Vision Center branded stores; and offers health maintenance organization and optometric services. National Vision Holdings, Inc. was founded in 1990 and is headquartered in Duluth, Georgia.Beauty Health NASDAQ:SKIN$1.14 +0.11 (+10.68%) Closing price 05/2/2025 04:00 PM EasternExtended Trading$1.13 -0.01 (-0.88%) As of 05/2/2025 06:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company's flagship product includes HydraFacial that enhance the skin to cleanse, extract, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a Delivery System designs to connects providers to the consumer's preferences to create a more personalized experience; consumables, such as single-use tips, solutions, and serums used to provide a hydrafacial treatment; SkinStylus SteriLock Microsystem, a microneedling device used for the treatment of enhancing appearance of surgical or traumatic hypertrophic scars on the abdomen and facial acne scarring in Fitzpatrick skin types I, II, and III; and Keravive, a treatment for scalp health. The company was founded in 1997 and is headquartered in Long Beach, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 04/28 - 05/02 Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be Cautious Meta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2 Why Spotify Stock Still Has Room to Run in 2025 Is It Time to Load Up on Bond ETFs? Palantir Earnings: 1 Bullish Signal and 1 Area of Concern Roblox Stock Gains Momentum and Can Top $100 in 2025 Visa Q2 Earnings Top Forecasts, Adds $30B Buyback Plan Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
